News|Articles|October 31, 2026

Stool biomarker uncovers silent bowel disease in uveitis patients

A simple stool test may reveal hidden bowel disease in patients whose only symptoms are in their eyes.

Patients with idiopathic uveitis or scleritis may have undiagnosed inflammatory bowel disease (IBD) detectable through serial fecal calprotectin (FC) testing—even in the complete absence of gastrointestinal symptoms—according to a prospective cohort study published in Frontiers in Medicine.¹ The findings suggest that a persistently elevated FC trajectory may identify a subgroup of patients who warrant formal gastroenterological evaluation.¹

Related to this article

October 21st, 2026

Brepocitinib meets all Phase 3 end points in noninfectious uveitis

CLARITY program data show significantly longer time to treatment failure and higher rates of steroid-free quiescence vs placebo.

October 20th, 2026

NeuroOp Guru at AAO 2026: Blurry vision in MS isn’t always a relapse

Andrew G. Lee, MD, and Drew Carey, MD, break down the link between optic neuritis and uveitis in central nervous system demyelinating disease.

October 20th, 2026

(FAQ) Inflammatory Eye Disease Week: What clinicians should know

Prevent Blindness marks IED Week, October 19 to 25, as new therapies and pivotal trials reshape care for uveitis and thyroid eye disease.

October 30th, 2026

Practical ways to extend anti-VEGF control in RVO, AMD, and DME

Jordana G. Fein, MD, MS, points to agent selection, payer requirements, and real-world treatment response across 3 retina cases.

(Image credit: Isa Mohammed, MD; Michael Singer, MD; Christina Weng, MD)

October 28th, 2026

The One Thing: Earlier AMD intervention, steroid education, and healthcare waste | Episode 4

Christina Y. Weng, MD, MBA, FASRS; Michael A. Singer, MD, and Isa S. K. Mohammed, MD, point to early retinal care, corticosteroid training, and regulation and waste.

(Image credit: Carl D. Regillo; Allen C. Ho; Modern Retina) The Wills Retina Report: Mapping late-stage gene therapy for wet AMD with Carl D. Regillo, MD, and Allen C. Ho, MD

October 27th, 2026

The Wills Retina Report: Mapping gene therapy for wet AMD with Carl D. Regillo, MD, and Allen C. Ho, MD

In the latest episode of The Wills Retina Report, Regillo and Ho discuss where gene therapy stands for retinal disease, from late-stage programs in neovascular age-related macular degeneration to earlier efforts in geographic atrophy and diabetic retinopathy.

October 27th, 2026

Retinal imaging as a window into atrial fibrillation

Patients with atrial fibrillation (AF) had measurable structural retinal changes in a large international study.

(Image credit: Modern Retina; Christina Weng; Amer Alsoudi; Monia Reding) The Retina TL;DR with Dr. Weng: Thriving in retina fellowship with Amer Alsoudi, MD, and Monia Reding, MD

October 23rd, 2026

The Retina TL;DR with Dr. Weng: Thriving in fellowship with Amer Alsoudi, MD, and Monia Reding, MD

In the latest episode of The Retina TL;DR with Dr. Weng—Part 2 of a special two-part series—host Christina Y. Weng, MD, MBA, FASRS, sits down with two more of her former residents for candid advice on transitioning into fellowship, balancing research and family, and what excites them most about the future of retina.